‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
Rosamund Vallings
1 *
+ Author Affiliations
- Author Affiliations
1 140 North Road, RD2 Papakura 2582, Auckland, New Zealand.
* Correspondence to: Vallings@xtra.co.nz
Journal of Primary Health Care 14(3) 283-284 https://doi.org/10.1071/HC22078
Published: 30 September 2022
© 2022 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)
References
[1] GoodFellow Symposium. The Lightning Process Training. 26–27 March 2022. Available at https://www.goodfellowunit.org/node/946722[2] GP CME Rotorua. The Lightning Process Training – Evidence Based option for Patients who are ‘Stuck’ (WS#166). 11 June 2022. Available at https://www.gpcme.co.nz/speakers.php
[3] Sweetman E, Kleffmann T, Edgar C, et al. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med 2020; 18 365
| A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.Crossref | GoogleScholarGoogle Scholar |
[4] Tate W, Walker M, Sweetman E, et al. Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and prevent relapse. Front Neurol 2022; 13 877772
| Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and prevent relapse.Crossref | GoogleScholarGoogle Scholar |
[5] Eaton-Fitch N, Du Preez S, Cabanas H, et al. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med 2022; 20 94
| Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.Crossref | GoogleScholarGoogle Scholar |
[6] National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE guideline [NG206]. 2021. Available at https://www.nice.org.uk/guidance/ng206
[7] National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. Evidence reviews for the nonpharmacological management of ME/CFS. NICE guideline [NG206]. 2021. Available at https://www.nice.org.uk/guidance/ng206/evidence/g-nonpharmacological-management-of-mecfs-pdf-9265183028
